Anzeige
Meldung des Tages: China kartiert den Meeresboden. Das Pentagon fordert Nickel. Ein Unternehmen mit 27 Mio. CAD Bewertung hat soeben reagiert.

INNOCAP INC News

Aktie
WKN:  ISIN:  US45773A1079 US-Symbol:  INNO
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

INNOCAP INC News

15.09.25 - PR Newswire
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference PR Newswire
29.08.25 - PR Newswire
Innocan Pharma Announces Details of Proposed Share Consolidation
Innocan Pharma Announces Details of Proposed Share Consolidation PR Newswire
27.08.25 - PR Newswire
Innocan Pharma Announces First Half Of 2025 Financial Results
Innocan Pharma Announces First Half Of 2025 Financial Results PR Newswire
22.08.25 - PR Newswire
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada PR Newswire
23.07.25 - PR Newswire
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering PR Newswire
03.07.25 - PR Newswire
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update PR Newswire
20.06.25 - PR Newswire
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
Innocan Pharma Announces Presentation of Narrative Review on Long-​Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference PR Newswire
13.06.25 - PR Newswire
Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach
Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-​Opioid Analgesic Approach PR Newswire
28.05.25 - PR Newswire
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update PR Newswire
06.05.25 - PR Newswire
Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief
Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »